Multifunctional Mesoporous Silicon Nanoparticles for MRI-Based Diagnostic Imaging and Glioma Therapy
ACS Applied Materials & Interfaces · 07.05.2025 · 17 (18) · 26416-26430
DOI: 10.1021/acsami.5c02882 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 22.04.2025. Verfasst von Huiru Zhu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Minis…. Hauptthemen laut MEDLINE: Glioma, Nanoparticles, Magnetic Resonance Imaging, Silicon. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
To overcome the limited efficacy of chemodynamic therapy (CDT) caused by insufficient hydrogen peroxide (H2O2) in the tumor microenvironment, we engineered a glutathione (GSH)-responsive multifunctional nanosystem, HCTG-C, based on hollow mesoporous organosilica nanoparticles. This system integrates tirapazamine (TPZ), glucose oxidase (GOx), in situ-synthesized copper sulfide (CuS), and CT2A glioma cell membrane coating to enable dual tumor-targeted therapy and self-imaging capabilities. The therapeutic mechanism relies on three synergistic cascades: (1) GOx-mediated glucose oxidation to deplete oxygen and generate H2O2, establishing a self-sustaining H2O2 supply; (2) GSH-triggered CuS conversion to Cu(I), amplifying Fenton-like reactions for efficient H2O2-to-reactive oxygen species conversion and ferroptosis induction; and (3) hypoxia-activated TPZ to exert cytotoxic effects, synergizing chemotherapy with CDT. Experimental results demonstrated that HCTG-C achieves real-time MRI monitoring via GSH depletion-driven Cu valence transitions, while its self-replenishing H2O2 and oxygen-activation mechanisms significantly enhance antitumor efficacy against CT2A glioma in vitro and in vivo. By innovatively combining H2O2 self-supply cascades, hypoxia-activated chemotherapy, and ferroptosis-driven CDT, this work presents a paradigm-shifting strategy for self-imaging-guided combinatorial therapy, advancing ferroptosis-based approaches for precision glioma treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Ch…
- Chongqing Key Laboratory of Ultrasound Molecular Imaging, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
ORCID-Profile: Jinhua Cai
Zitieren
APA
Zhu, H., Ni, X., Su, J., Qin, Y., He, X., Liu, B., Ding, S., Wang, H., Zhang, X., Huang, J., Hu, Q., Ma, R., & Cai, J. (2025). Multifunctional Mesoporous Silicon Nanoparticles for MRI-Based Diagnostic Imaging and Glioma Therapy. ACS Applied Materials & Interfaces, 17(18), 26416-26430. https://doi.org/10.1021/acsami.5c02882
Vancouver
Zhu H, Ni X, Su J, Qin Y, He X, Liu B, et al. Multifunctional Mesoporous Silicon Nanoparticles for MRI-Based Diagnostic Imaging and Glioma Therapy. ACS Applied Materials & Interfaces. 2025;17(18):26416-26430. doi:10.1021/acsami.5c02882
BibTeX
@article{Zhu2025,
author = {Zhu, Huiru and Ni, Xiaoying and Su, Jiaxin and Qin, Yong and He, Xiaoya and Liu, Bo and Ding, Shuang and Wang, Haoru and Zhang, Xiangmin and Huang, Jie and Hu, Qian and Ma, Ruofei and Cai, Jinhua},
title = {Multifunctional Mesoporous Silicon Nanoparticles for MRI-Based Diagnostic Imaging and Glioma Therapy},
journal = {ACS Applied Materials & Interfaces},
year = {2025},
volume = {17},
number = {18},
pages = {26416--26430},
doi = {10.1021/acsami.5c02882}
}
EUVIMED